Impact of COVID-19 on Sales Activities and Demand
First written in FY2021-Q1. 10 of 17 entries say "Mitigated", first in FY2021-Q3. Latest entry: FY2026-H1.
0 other companies' latest entry also says "Mitigated".
- FY2026-H1MitigatedAnnual report
「The Company believes that cosmetics demand is gradually recovering. It also believes that its operating environment is gradually improving, as conditions for holding various training sessions and seminars have become more favorable.」
The company indicates that the environment for holding training sessions and seminars has been restored since the infectious disease outbreak, and that cosmetics demand and the business environment are improving. - FY2025MitigatedAnnual report
「The impact of COVID-19 and other factors on society as a whole significantly affected the business foundation that the company values: door-to-door and face-to-face sales, through which people meet and communicate directly while pursuing quality and functionality in products and providing services from the customer’s perspective. However, the social environment has gradually improved, and the company expects its corporate activities to become more active going forward.」
While stating that the impact of the infectious disease on face-to-face sales is improving, the company continues to disclose the risk that training and sales activities may be restricted if a new infectious disease resurges. - FY2025-H1MitigatedAnnual report
「The spread of COVID-19 has begun to subside, and personal consumption remained firm. …As the environment for holding various training sessions and seminars has improved, the company believes that the business environment has gradually become more favourable.」
Against the backdrop of the subsiding infectious disease outbreak and the recovery of the environment for holding training sessions and seminars, the company continues to recognise that the impact of the infectious disease on sales activities and demand is improving. - FY2024MitigatedAnnual report
「However, as the infectious disease was reclassified from Category 2 to Category 5 in May 2023, the company expects its corporate activities to become more active going forward than in the most recent fiscal year. In May 2023, the company launched the “Good-bye COVID-19” campaign and has worked as one to develop “users who smile freely without masks.”」
The filing states that the impact of the infectious disease on sales and corporate activities is improving against the backdrop of the move to Category 5 and the “Good-bye COVID-19” campaign. However, the risk of restrictions if a new infectious disease resurges remains. - FY2024-Q3MitigatedAnnual report
「During the cumulative third-quarter period, Japan's economy experienced improving prospects for future growth as the classification of COVID-19 was lowered from Category 2 to Category 5 in May 2023 and the surge in raw material prices subsided. As in the tourism and food-service industries, cosmetics demand has also recovered as mask-wearing has been phased out.」
Against the backdrop of the move to Category 5 and progress toward going mask-free, cosmetics demand has recovered, and the filing states that the impact of the infectious disease on sales activities and demand is improving. - FY2024-Q2MitigatedAnnual report
「COVID-19 was reclassified from Category 2 to Category 5, and activity in the tourism and food-service industries has gradually returned. Similarly, demand in the cosmetics industry is recovering sharply.」
Against the backdrop of the move to Category 5 and the recovery in demand, the company continues to recognise that the impact of the infectious disease on sales activities and demand is improving. - FY2024-Q1MitigatedAnnual report
「COVID-19 was reclassified from Category 2 to Category 5, and activity in the tourism and food-service industries has gradually returned. Similarly, demand in the cosmetics industry is recovering sharply.」
Against the backdrop of the move to Category 5 and the recovery in demand, the company recognises that the impact of the infectious disease on sales activities and demand is improving. - FY2023MitigatedAnnual report
「However, as the infectious disease was reclassified from Category 2 to Category 5 in May 2023, the company expects its corporate activities to become more active going forward than in the most recent 3 fiscal years.」
In light of the move to Category 5, the company expects its corporate activities to become more active going forward. At the same time, it continues to disclose the risk that sales activities, training and other operations may be restricted if the disease resurges. - FY2023-Q3MitigatedAnnual report
「With regard to the outlook, the company operates on the assumption that “due to mutations in the coronavirus, the impact of COVID-19 will remain unavoidable for the next several years.” However, in light of the government’s policy to reclassify COVID-19 from Category 2 to Category 5, it expects the impact of COVID-19 to gradually improve. The sales organisation has also responded flexibly to COVID-19 by taking measures to prevent infection and using online tools, among other initiatives. By maintaining contact with sales representatives and customers, sales activities have become more active than before, and the organisation has adapted to the changing environment of the “With COVID-19 era.”」
While maintaining the assumption that the impact of the infectious disease will remain unavoidable for the next several years, the company expects the impact to gradually improve against the backdrop of the government’s policy to move to Category 5 and the sales organisation’s adaptation through online tools and other measures. - FY2023-Q2MaterialisedAnnual report
「However, the seventh wave of COVID-19 that occurred this summer forced some group training sessions to be cancelled or postponed, and significantly restricted face-to-face sales activities」
The filing states that the impact of the seventh wave actually materialised in the form of cancellations and postponements of group training, restrictions on face-to-face sales activities, and a 27.3% year-on-year decline in revenue. - FY2022RestatedAnnual report
「During the fiscal year, the spread of COVID-19 forced many training sessions to be cancelled or postponed. However, attendance recovered slightly year on year as a result of various infection-control measures.」
While the risk of training sessions being cancelled or postponed due to the infectious disease persists, training attendance recovered slightly year on year as a result of infection-control measures. - FY2022-Q2RestatedAnnual report
「Regarding the outlook, we are proceeding on the assumption that the impact of COVID-19 will be unavoidable for the next several years due to mutations of the virus, but we expect its impact to gradually improve as vaccination becomes more widespread.」
While maintaining the assumption that the impact of the infectious disease will remain unavoidable for the next several years, the company expects a gradual improvement driven by vaccine uptake. - FY2022-Q1WorsenedAnnual report
「Regarding the outlook, we are proceeding on the assumption that the impact of COVID-19 will be unavoidable for the next several years due to mutations of the virus, but we expect its impact to gradually improve as vaccination becomes more widespread.」
The assumption that the impact of COVID-19 will remain unavoidable for the next several years has now been stated explicitly, with a prolonged impact expected. A gradual improvement driven by vaccine uptake is also noted. - FY2021RestatedAnnual report
「A situation has arisen in which our strength, namely, face-to-face and door-to-door sales that involve people meeting and communicating directly while pursuing product quality and functionality and providing services from the customer's perspective, cannot be fully brought to bear.」
The annual report continues to disclose the risk that the pandemic will constrain face-to-face sales, training, and meetings. - FY2021-Q3MitigatedAnnual report
「Meanwhile, during the third-quarter accounting period, revenue recovered to 141.9% of the same quarter of the previous year.」
The impact of the pandemic continued, resulting in a 13.2% decline in revenue for the cumulative third quarter, although revenue for the third quarter alone recovered to 141.9% of the previous year's level. - FY2021-Q2WorsenedAnnual report
「During the cumulative second quarter, the impact of the COVID-19 pandemic resulted in revenue of ¥1,558 million, down 24.8% from the same period of the previous year, representing a "significant decline in revenue."」
The impact of the pandemic and the state of emergency became further evident in a 24.8% year-on-year decline in revenue, restrictions on face-to-face activities and group training, and lower orders for core products. - FY2021-Q1First statedAnnual report
「During the cumulative first quarter, revenue decreased 12.9% from the same period of the previous year due to the COVID-19 pandemic and the related state of emergency, and the company again faced difficulties. However, its sales organization has maintained resilient sales capabilities, and monthly revenue in June, after the state of emergency ended, recovered to 137.3% of the previous year's level, indicating a recovery trend.」
The COVID-19 pandemic and the state of emergency actually resulted in restrictions on sales activities, lower demand, and a 12.9% decline in revenue. Meanwhile, monthly revenue in June reached 137.3% of the previous year's level, and the company also noted signs of recovery.